Posted on 16/03/202108/07/2024Solid Biosciences Reports Efficacy and Safety Data from the Ongoing IGNITE DMD Clinical Trial https://investors.solidbio.com/news-releases/news-release-details/solid-biosciences-reports-efficacy-and-safety-data-ongoing
Posted on 13/03/202108/07/2024bluebird bio announces that lentiviral vector BB305 is unlikely to be the cause of AML in clinical study of LentiGlobin for Sickle Cell Disease 4 4 https://investor.bluebirdbio.com/news-releases/news-release-details/bluebird-bio-provides-updated-findings-reported-case-acute
